Alvea
•
Applied to How to Speedrun a New Drug Application (Interview with Alvea's former CEO) 2mo ago
•
Applied to Alvea’s Story, Wins, and Challenges [Unofficial] 6mo ago
•
Applied to Alvea Wind Down Announcement [Official] 6mo ago
•
Applied to Complementary notes on Alvea [unofficial] 6mo ago
•
Applied to Announcing Alvea—A COVID Vaccine Project 2y ago
Alvea is a startup biotechnology company focused on building a streamlined platform for developing and deploying DNA vaccines against COVID-19 variants and other pathogens. It launched in February 2022.[1]
Further reading
Fish, Kyle (2022) Announcing Alvea—An EA COVID vaccine project, Effective Altruism Forum, February 16.
External links
Alvea. Official website.
Related entries
biosecurity | COVID-19 pandemic | pandemic preparedness | vaccines
- ^
PR Newswire (2022) Alvea launches scalable, shelf- stable DNA vaccine development against new SARS-CoV-2 variants, PR Newswire, February 16.
•
Created by Pablo at 2y
Apply for a job.